injectiespuit

Currently, our vaccine pipeline focusses on three disease areas: airborne vaccines, mucosal-borne vaccines, and vector-borne vaccines.

Airborne vaccines

Airborne diseases are caused by pathogens that are small enough to be discharged from an infected person via coughing, talking, sneezing, close personal contact or even by laughing.  

ZIP-09

Undisclosed

ZIP-1642

COVID-19

Disease

Discovery

Preclinical

Phase 1

Phase 2

Phase 3

Mucosal-borne vaccines

Mucosal borne diseases occur through direct contact with the mucous membranes of the mouth and genitals. They are often spread through skin-to-skin contact such as kissing and sexual intercourse. 

Disease

Discovery

Preclinical

Phase 1

Phase 2

Phase 3

ZIP-10

Undisclosed

ZIP-11

Undisclosed

ZIP-08

Undisclosed

Vector-borne vaccines

Vector borne diseases are infections transmitted by bites of infected arthropods such as mosquitos, ticks and flies.

Disease

Discovery

Preclinical

Phase 1

Phase 2

Phase 3

ZIP-12

Undisclosed

ZIP-13

Undisclosed

Our Pipeline

 Address. Legeweg 157C,  B-8020 Oostkamp, Belgium

© 2019 Ziphius Therapeutics NV